Caren van Roekel

72 Chapter 2 13. Gray B. Patent application WO 02/34300 A1. Polymer based radionuclide containing particulate material. 2002. 14. Elschot M, Nijsen JF, Dam AJ, De Jong HW. Quantitative evaluation of scintillation camera imaging characteristics of isotopes used in liver radioembolization. PloS One. 2011. 15. van de Maat GH, Seevinck PR, Elschot M, Smits ML, de Leeuw H, van Het Schip AD, et al. MRI-based biodistribution assessment of holmium-166 poly(L- lactic acid) microspheres af ter radioembolisation. Eur Radiol. 2013;23(3):827-35. Epub 2012/09/28. 16. Nijsen JF, Seppenwoolde JH, Havenith T, Bos C, Bakker CJ, van het Schip AD. Liver tumors: MR imaging of radioactive holmium microspheres--phantom and rabbit study. Radiology. 2004;231(2):491- 9. Epub 2004/03/20. 17. Vente MA, Nijsen JF, de Roos R, van Steenbergen MJ, Kaaijk CN, Koster- Ammerlaan MJ, et al. Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomedical microdevices. 2009;11(4):763-72. Epub 2009/02/26. 18. Virdee PS, Moschandreas J, Gebski V, Love SB, Francis EA, Wasan HS, et al. Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE- Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer. JMIR research protocols. 2017;6(3):e43. Epub 2017/03/30. 19. van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J Clin Oncol. 2016;34(15):1723- 31. Epub 2016/02/24. 20. Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, et al. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. J Hepatol. 2013;59:753-61. 21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55. 22. American College of Radiology. CT/MRI LI-RADS v2018. 23. van den Hoven AF, Braat MN, Prince JF, van Doormaal PJ, van Leeuwen MS, Lam MG, et al. Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol. Eur Radiol. 2017;27(1):61-9. Epub 2016/04/25. 24. Rosenbaum CE, van den Bosch MA, Veldhuis WB, Huijbregts JE, Koopman M, Lam MG. Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases. Eur Radiol. 2013;23(4):931- 7. Epub 2012/11/01.